Class II · ModerateRecall completed
Lisinopril Tablets USP
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot # Q000232, exp. date 01/2022
Where it was soldProduct was distributed to OH and may have been further distributed throughout the United States.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byLupin Limited, Nagpur INDIA, For BluePoint Laboratories foreign manufacturer
| Distributed by / for | Lupin Pharmaceuticals Inc. |
| NDC | 68001-334-08 |
Show the full FDA record
| Full product label | Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Product was distributed to OH and may have been further distributed throughout the United States. |
| Quantity | 11,688 bottles |
| Recall initiated | 2020-07-17 |
| Report date | 2020-08-05 |
| Recall completed | 2021-08-26 |
| Recall number | D-1413-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.